Mark D. Okusa, M.D.

NPI 1679618763ActiveIndividual· Internal Medicine, Nephrology· Charlottesville, VA

Internal Medicine, Nephrology (M.D.) in Charlottesville, Virginia, trained at Virginia Commonwealth University, School of Medicine (class of 1982). 165 Medicare patients in 2024, $31,686 paid; nearly all of their 305 Part D prescriptions were generic (94%). Astrazeneca Uk Limited reported $1,470 in payments in 2024, mostly consulting fees.

Overview

NPI	1679618763
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Feb 20, 2007
Last updated in NPPES	Sep 18, 2026
Certified by provider	Sep 18, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Nephrology Primary	207RN0300X	0101035775	VA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Nephrology (VA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	165
Services billed	518 across 14 procedure codes
Paid by Medicare	$31,686

Part D prescriptions in 2024

Prescriptions (claims)	305 · 774 30-day fills
Patients	60
Total drug cost	$17,385
Generic share	94% of claims

Medicare sources and data years

Education and affiliations

Medical school	Virginia Commonwealth University, School of Medicine
Graduation year	1982
Medicare specialty	Nephrology
Secondary specialties	Critical Care (Intensivists)